| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | L5L45YGP1O |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| CROSS-LINKING AGENT | Receptor protein-tyrosine kinase erbB-2 cross-linking agent | PubMed |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Breast Neoplasms | 2 | D001943 | ClinicalTrials |
| Neoplasms | 1 | D009369 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL2108029 |
| FDA SRS | L5L45YGP1O |
CONTENTS